JPRN-UMIN000005051已完成未知
A retrospective study of second-line platinum containing chemotherapy in patients with endometrial cancer previously treated with platinum therapy - SGSG012 study
Sankai Gynecologic Oncology Study Group0 个研究点目标入组 800 人开始时间: 2011年2月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients with uterine sarcoa.
研究者
相似试验
已完成
2 期
Phase2 study of platinum doublet with pemetrexed in non-squamous non-small cell lung cancer with brain metastases.on-small cell Lung CancerJPRN-UMIN000007643orth Japan Lung Cancer Study Group32
Unknown
2 期
Platinum Rechallenge in Patients With Platinum-sensitive mTNBCMetastatic Breast CancerNCT02607215Fudan University84
进行中（未招募）
1 期
Platinum-doublet chemotherapy combined with nivolumab as first treatment for unresectable, locally advanced or metastatic neuroendocrine neoplasms of the stomach, intestines or pancreas or of unknown origin.EUCTR2019-001546-18-ESGrupo Español de Tumores Neuroendocrinos y Endocrinos (GETNE)38
终止
2 期
Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal CancersPlatinum Sensitive Relapsed Ovarian CancerNCT00247988University of Saskatchewan38
招募中
2 期
TROG 20.01 CHEST RT: Chemotherapy and Immunotherapy in extensive stage small cell lung cancer with thoracic radiotherapyExtensive Stage Small Cell Lung CancerCancer - Lung - Small cellLung CancerCancerACTRN12621000586819Trans Tasman Radiation Oncology Group35